Search clinical trials for: CC-1 and Toczilizumab

Total 13071 results

German Cancer Research Center
University Hospital Tuebingen

Terminated

Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung

Lung Cancer Squamous Cell

Germany
Celgene

Completed

2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects

Healthy

United States
Hoffmann-La Roche

Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma

United States, Israel, Italy, Spain, United Kingdom
University of Alberta

Completed

Chest Compression and Sustained Inflation

Newborn Infants Having Asystole or Bradycardia at Birth

Canada
University Hospital Tuebingen

Recruiting

Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer (ProSperACC-1)

Prostate Cancer Recurrent

Germany
University Hospital Tuebingen
German Cancer Research Center

Recruiting

the Bispecific PSMAxCD3 Antibody CC-1 in Patients With Castration Resistant Prostate Carcinoma (PSMAxCD3)

Castration-Resistant Prostatic Cancer

Germany
Hospital Universitario Ramon y Cajal

Terminated

Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) (COVITOZ-01)

Covid19

Spain
Hoffmann-La Roche

Completed

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

France, Germany, Italy, Spain, United Kingdom, Hong Kong, United States, Colombia, Brazil, Canada, New Zealand, South Africa, Philippines, Russian Federation, Thailand, Singapore, Bulgaria, Mexico, Australia, Lithuania, Poland, Ar... and more
Heilongjiang University of Chinese Medicine
The University of Hong Kong; Yale University; Jiangsu Province Hospital of Traditional... and other collaborators

Completed

Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome (PCOSAct)

Polycystic Ovary Syndrome | Infertility | Pregnancy

China
University of Alberta

Completed

SI + CC Versus 3:1 C:V Ratio During Neonatal CPR (SURV1VE)

Bradycardia | Heart Arrest | Birth Asphyxia

Canada, Austria
Marius Henriksen

Terminated

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (TOCIVID)

Corona Virus Disease

Denmark
Hellenic Institute for the Study of Sepsis

Completed

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction (ESCAPE)

Virus Diseases | COVID-19 | Corona Virus Infection | Macrophage Activation Syndrome

Greece
Rigshospitalet, Denmark

Completed

Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

Appetitive Behavior | Physical Stress | Interleukin-6 Inhibition

Denmark
Assistance Publique - Hôpitaux de Paris

Unknown

Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis (RUBI)

Uveitis | Biotherapy

France
Kaiser Clinic and Hospital

Completed

Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons in the Treatment of Obesity

Obesity | Metabolic Syndrome

Brazil
Universidad Autonoma de Nuevo Leon

Completed

Metabolic Syndrome and Functional Food

Metabolic Syndrome

Mexico
Hoffmann-La Roche

Completed

A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

France, Israel, Italy, Hong Kong, Switzerland, Canada, Germany, Mexico, Austria, Thailand, Singapore, Hungary, Bulgaria, Australia, Argentina, Slovakia, Brazil
University of Houston

Recruiting

Dual Use Approach Bias Training for Nicotine Addiction

Tobacco Smoking | Electronic Cigarette Use | Substance Use

United States
Assistance Publique Hopitaux De Marseille

Unknown

A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease (INFLAMMACOV)

Covid19

France
Celgene

Completed

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

United States, United Kingdom
National Institute of Allergy and Infectious Diseases...

Recruiting

Tocilizumab in Lung Transplantation (ALL IN LUNG)

Lung Transplant

United States, Canada
Fakultas Kedokteran Universitas Indonesia

Unknown

A Trial Comparing Pain During Local Tumesent Injection In Fingers Using Different Syringe-Needle Combinations

Pain | Anesthesia, Local | Injection Site | Infiltration

Indonesia
University Hospital, Toulouse

Recruiting

Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy (RAIPONS)

Kidney Transplantation | Graft Failure

France
Flavio Vincenti

Completed

Tocilizumab for Renal Graft Inflammation

Late Complication From Kidney Transplant

United States
Tel-Aviv Sourasky Medical Center
Rambam Health Care Campus; Assaf-Harofeh Medical Center; Bnai Zion Medical Center

Unknown

Efficacy and Safety of Tocilizumab in Adult's Still Disease

Adult's Still Disease

Israel
University Hospital, Brest
Roche Chugai

Completed

Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE

Polymyalgia Rheumatica

France
University of Colorado, Denver
Bristol-Myers Squibb

Recruiting

CC-486 and Venetoclax for Acute Myeloid Leukemia

AML

United States
Peking University First Hospital

Unknown

Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019

COVID-19

China
Hadassah Medical Organization
Sheba Medical Center; Wolfson Medical Center

Unknown

The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation

Covid19 Pneumonia

Israel
Hospital for Special Surgery, New York
Genentech, Inc.

Completed

Study of Tocilizumab to Treat Polymyalgia Rheumatica

Polymyalgia Rheumatica (PMR)

United States
Tel Hai College
Saint Vincent De Paul - French Hospital - Nazareth

Recruiting

The Effect of Energy Drinks Consumption on Acute Physiological and Psychological Responses of Israeli Arab Adolescents (EDE)

Energy Drinks

Israel
Hoffmann-La Roche

Recruiting

A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2)

Multiple Myeloma

United States, Italy, Spain, Australia, Belgium, Israel, Germany, France
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Completed

New Cross Linked Hyaluronan Gel After Deep Infiltrating Endometriosis Surgery (HYALOENDOQoL)

Quality of Life | Endometriosis | Surgery | Adhesion
Mycenax Biotech Inc.

Completed

Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers

Pharmacokinetics

Australia
Celgene

Terminated

A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

United States
Celgene

Completed

Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Cytonics Corporation

Unknown

APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee

Pain | Osteoarthritis

United States
Tactile Medical

Terminated

Determining Swallow Outcomes in Head & Neck Lymphedema Subjects Receiving Early Intervention With Pneumatic Compression

Head and Neck Lymphedema

United States
Philip Morris Products S.A.

Completed

User Acceptability of a Nicotine Lactate Delivery System (P3L)

Smoking

United States
Celgene
ICON Clinical Research

Completed

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

Melanoma | Neoplasm Metastasis

Australia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
The First Affiliated Hospital of Soochow University

Recruiting

Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients

Multiple Myeloma

China
Fu-Dong Shi

Completed

A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD

Neuromyelitis Optica | Neuromyelitis Optica Spectrum Disorders | Devic's Disease

China
Celgene

Recruiting

Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

United States, Spain, Sweden, Germany, Italy, Japan
Hoffmann-La Roche

Completed

A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium, Germany, Spain, Sweden, United Kingdom, United States, Brazil, Greece, Portugal, Turkey, Finland, Switzerland, Australia, Mexico, Czech Republic
Celgene

Completed

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Lymphoma | Lymphoma, Large B-Cell, Diffuse | Glioblastoma | Multiple Myeloma | Primary Central Nervous System Lymphoma | Pleiotropic Pathway Modifier

United States, Spain, Belgium, France, Italy
Ankara Education and Research Hospital

Completed

The Effect of Perineural Dextrose Injection in Patients With Ulnar Neuropathy at the Elbow

Ulnar Neuropathies

Turkey
Hoffmann-La Roche

Completed

EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis

Rheumatoid Arthritis

Greece
Ramathibodi Hospital

Completed

Perioperative Outcome of Corticosteroids in Transforaminal Endoscopic Lumbar Discectomy

Lumbar Disc Herniation
University Hospital, Ghent
Belgium Health Care Knowledge Centre

Completed

Treatment of COVID-19 Patients With Anti-interleukin Drugs (COV-AID)

COVID-19

Belgium
SCRI Development Innovations, LLC
Janssen Research & Development, LLC

Recruiting

Outpatient Administration of Teclistamab for Multiple Myeloma

Multiple Myeloma

United States

Search clinical trials for: CC-1 and Toczilizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations